ARCHIVES

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 3 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Urges Moratorium On Sale, Use of Silicone Breast Implants

January 10, 1992

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients

April 27, 2012

DCT Announces Neutron Therapy RFP Available

January 19, 1979

In Brief: Sporn Wins BMS Cancer Research Award; Dana-Farber To Try To Affect Teen Health

April 3, 1998

FEBT, For Pain Control, Shows Positive Results In Phase III

May 26, 2006